Biotage AB financials
Biotage AB
Country: SE Reporting currency: SEK Latest annual report: 2024-12-31
LEI:
529900SR87NBUKX74L58 Financial statements
(SEK, as reported — unscaled; 94 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 2.06B | SEK 1.86B |
| Cost of sales | SEK 767.0M | SEK 713.0M |
| Gross profit | SEK 1.29B | SEK 1.15B |
| Other income | SEK 82.0M | SEK 16.0M |
| Administrative expenses | SEK 264.0M | SEK 212.0M |
| Operating profit (EBIT) | SEK 383.0M | SEK 314.0M |
| Net finance income / (cost) | -SEK 55.0M | -SEK 11.0M |
| Finance costs | SEK 67.0M | SEK 41.0M |
| Profit before tax | SEK 328.0M | SEK 303.0M |
| Income tax expense | SEK 44.0M | SEK 57.0M |
| Profit for the year | SEK 284.0M | SEK 246.0M |
| — attributable to owners | SEK 284.0M | SEK 246.0M |
| Total comprehensive income | SEK 581.0M | SEK 91.0M |
| Per share | ||
| Basic EPS | SEK 3.55 | SEK 3.34 |
| Diluted EPS | SEK 3.55 | SEK 3.33 |
| Free cash flow / share | SEK 4.04 | SEK 3.49 |
| Cash flow statement | ||
| Net cash from operating activities | SEK 413.0M | SEK 284.0M |
| Income taxes paid | SEK 126.0M | SEK 96.0M |
| Net cash from investing activities | -SEK 456.0M | SEK 35.0M |
| Purchase of PP&E (capex) | SEK 89.0M | SEK 26.0M |
| Purchase of intangibles | SEK 80.0M | SEK 65.0M |
| Net cash from financing activities | -SEK 156.0M | -SEK 142.0M |
| Repayments of borrowings | SEK 30.0M | SEK 38.0M |
| Net change in cash | -SEK 199.0M | SEK 177.0M |
| Balance sheet | ||
| Total assets | SEK 5.10B | SEK 4.93B |
| Non-current assets | SEK 3.75B | SEK 3.48B |
| Property, plant & equipment | SEK 245.0M | SEK 187.0M |
| Right-of-use assets | SEK 85.0M | SEK 97.0M |
| Intangible assets & goodwill | SEK 2.56B | SEK 2.39B |
| Current assets | SEK 1.32B | SEK 1.45B |
| Inventories | SEK 458.0M | SEK 437.0M |
| Trade & other receivables | SEK 357.0M | SEK 321.0M |
| Cash & equivalents | SEK 434.0M | SEK 594.0M |
| Total equity | SEK 4.11B | SEK 3.66B |
| Non-current liabilities | SEK 409.0M | SEK 569.0M |
| Long-term borrowings | SEK 150.0M | SEK 150.0M |
| Lease liabilities (non-current) | SEK 66.0M | SEK 76.0M |
| Current liabilities | SEK 573.0M | SEK 705.0M |
| Lease liabilities (current) | SEK 34.0M | SEK 33.0M |
| Deferred tax liabilities | SEK 190.0M | SEK 193.0M |
| Derived metrics | ||
| Free cash flow | SEK 324.0M | SEK 258.0M |
| Operating margin | 18.6% | 16.9% |
| Net margin | 13.8% | 13.2% |
| Return on equity | 6.9% | 6.7% |
| Cash conversion ratio | 1.45× | 1.15× |
| Capex coverage | 4.64× | 10.92× |
| Other reported items | ||
| Adjusted Weighted Average Shares | 80.1M | 74.0M |
| Adjustments For Decrease Increase In Inventories | SEK 9.0M | -SEK 20.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | SEK 0 | -SEK 97.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | SEK 185.0M | SEK 149.0M |
| Adjustments For Fair Value Gains Losses | -SEK 61.0M | -SEK 9.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | SEK 35.0M | SEK 31.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | SEK 17.0M | -SEK 18.0M |
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | -SEK 167.0M | -SEK 163.0M |
| Cash Flows From Used In Operations Before Changes In Working Capital | SEK 369.0M | SEK 370.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | SEK 287.0M | -SEK 125.0M |
| Comprehensive Income Attributable To Owners of Parent | SEK 581.0M | SEK 91.0M |
| Deferred Tax Assets | SEK 63.0M | SEK 31.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | SEK 128.0M | SEK 106.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | SEK 1.65 | — |
| Dividends Recognised As Distributions To Owners of Parent | SEK 128.0M | SEK 106.0M |
| Dividends Recognised As Distributions To Owners Per Share | SEK 1.65 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 39.0M | -SEK 24.0M |
| Equity and Liabilities | SEK 5.10B | SEK 4.93B |
| Finance Income | SEK 12.0M | SEK 30.0M |
| Gains Losses On Exchange Differences On Translation Net of Tax | SEK 297.0M | -SEK 155.0M |
| Increase Decrease In Working Capital | -SEK 44.0M | SEK 86.0M |
| Increase Decrease Through Sharebased Payment Transactions | SEK 0 | SEK 3.0M |
| Increase Decrease Through Transfers and Other Changes Equity | SEK 1.0M | SEK 2.0M |
| Interest Paid Classified As Operating Activities | SEK 17.0M | SEK 10.0M |
| Interest Received Classified As Operating Activities | SEK 12.0M | SEK 9.0M |
| Issue of Equity | SEK 1.0M | SEK 2.03B |
| Issued Capital | SEK 113.0M | SEK 112.0M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | SEK 9.0M | SEK 0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | SEK 35.0M | SEK 0 |
| Operating Expense Excluding Cost of Sales | SEK 906.0M | SEK 835.0M |
| Other Adjustments For Noncash Items | SEK 26.0M | SEK 41.0M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | SEK 0 | -SEK 1.0M |
| Other Comprehensive Income | SEK 297.0M | -SEK 155.0M |
| Other Current Financial Liabilities | SEK 142.0M | SEK 221.0M |
| Other Current Nonfinancial Liabilities | SEK 306.0M | SEK 349.0M |
| Other Expense By Function | SEK 11.0M | SEK 23.0M |
| Other Longterm Provisions | SEK 3.0M | SEK 3.0M |
| Other Noncurrent Financial Assets | SEK 25.0M | SEK 23.0M |
| Other Noncurrent Financial Liabilities | SEK 0 | SEK 147.0M |
| Other Shortterm Provisions | SEK 4.0M | SEK 4.0M |
| Proceeds From Issuing Shares | SEK 2.0M | SEK 0 |
| Proceeds From Sale Or Issue of Treasury Shares | SEK 0 | SEK 2.0M |
| Research and Development Expense | SEK 180.0M | SEK 159.0M |
| Retained Earnings | SEK 1.54B | SEK 1.38B |
| Sale Or Issue of Treasury Shares | SEK 1.0M | SEK 3.0M |
| Selling Expense | SEK 533.0M | SEK 457.0M |
| Trade and Other Current Payables To Trade Suppliers | SEK 87.0M | SEK 98.0M |
| Weighted Average Shares | 80.0M | 73.9M |
Methodology
Every line item above is a fact tagged in Biotage AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.